+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Continuous Manufacturing Market Research Report by Distribution, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968719
  • Report
  • April 2022
  • Region: Global
  • 210 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • 3P Biopharmaceuticals
  • ABN Cleanroom Technology
  • Bayer AG
  • Coperion GmbH
  • GEA
  • Johnson & Johnson’s,
The Global Pharmaceutical Continuous Manufacturing Market size was estimated at USD 527.32 million in 2021, USD 594.13 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.63% to reach USD 1,076.65 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Continuous Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distribution, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Application, the market was studied across Active Pharmaceutical Ingredient, Biologics, and Dry Powders.
  • Based on End User, the market was studied across Contract Manufacturing Organization and Pharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Continuous Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Continuous Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Continuous Manufacturing Market, including 3P Biopharmaceuticals, Abbott, AbbVie Inc., ABN Cleanroom Technology, AC Immune, Baker Perkins Ltd, Bayer AG, Bosch Packaging Technology, Chemtrix, Continuous Pharmaceutical, Coperion GmbH, Corning Life Sciences, Eli Lilly and Company, GEA, Gebrüder Lödige Maschinenbau GmbH, Genzyme Corporation, Glatt GmbH, Hosokawa Micron Corporation, Janssen Global Services, LLC, Johnson & Johnson’s,, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Novartis AG, S K Biotek Ltd, Scott Equipment Company, Siemens AG, Sturtevant, Inc, Syntegon Technology GmbH, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Continuous Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Continuous Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Continuous Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Continuous Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Continuous Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Continuous Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Continuous Manufacturing Market?
Frequently Asked Questions about the Global Pharmaceutical Continuous Manufacturing Market

What is the estimated value of the Global Pharmaceutical Continuous Manufacturing Market?

The Global Pharmaceutical Continuous Manufacturing Market was estimated to be valued at $527.3 Million in 2021.

What is the growth rate of the Global Pharmaceutical Continuous Manufacturing Market?

The growth rate of the Global Pharmaceutical Continuous Manufacturing Market is 12.6%, with an estimated value of $1076.7 Million by 2027.

What is the forecasted size of the Global Pharmaceutical Continuous Manufacturing Market?

The Global Pharmaceutical Continuous Manufacturing Market is estimated to be worth $1076.7 Million by 2027.

Who are the key companies in the Global Pharmaceutical Continuous Manufacturing Market?

Key companies in the Global Pharmaceutical Continuous Manufacturing Market include 3P Biopharmaceuticals, Abbott, AbbVie Inc., ABN Cleanroom Technology, AC Immune, Baker Perkins Ltd, Bayer AG, Bosch Packaging Technology and Continuous Pharmaceutical.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3P Biopharmaceuticals
  • ABN Cleanroom Technology
  • Bayer AG
  • Coperion GmbH
  • GEA
  • Johnson & Johnson’s,

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to cost-effective approach
5.1.1.2. Favorable regulatory policies for adoption of continuous manufacturing systems
5.1.1.3. Increasing application owing to better efficiency of manufacturing operations
5.1.2. Restraints
5.1.2.1. Dearth of technical and regulatory clarities
5.1.3. Opportunities
5.1.3.1. Emerging collaborations between industry and academics
5.1.3.2. Ongoing growth in generic manufacturing
5.1.4. Challenges
5.1.4.1. High infrastructural investments and concerns regarding cleaning validation
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Pharmaceutical Continuous Manufacturing Market, by Distribution
6.1. Introduction
6.2. Hospital Pharmacy
6.3. Online Pharmacy
6.4. Retail Pharmacy
7. Pharmaceutical Continuous Manufacturing Market, by Application
7.1. Introduction
7.2. Active Pharmaceutical Ingredient
7.3. Biologics
7.4. Dry Powders
8. Pharmaceutical Continuous Manufacturing Market, by End User
8.1. Introduction
8.2. Contract Manufacturing Organization
8.3. Pharmaceutical Companies
9. Americas Pharmaceutical Continuous Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Continuous Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Pharmaceutical Continuous Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3P Biopharmaceuticals
13.2. Abbott
13.3. AbbVie Inc.
13.4. ABN Cleanroom Technology
13.5. AC Immune
13.6. Baker Perkins Ltd
13.7. Bayer AG
13.8. Bosch Packaging Technology
13.9. Chemtrix
13.10. Continuous Pharmaceutical
13.11. Coperion GmbH
13.12. Corning Life Sciences
13.13. Eli Lilly and Company
13.14. GEA
13.15. Gebrüder Lödige Maschinenbau GmbH
13.16. Genzyme Corporation
13.17. Glatt GmbH
13.18. Hosokawa Micron Corporation
13.19. Janssen Global Services, LLC
13.20. Johnson & Johnson’s,
13.21. Korsch AG
13.22. L.B. Bohle Maschinen + Verfahren GmbH
13.23. Novartis AG
13.24. S K Biotek Ltd
13.25. Scott Equipment Company
13.26. Siemens AG
13.27. Sturtevant, Inc
13.28. Syntegon Technology GmbH
13.29. Thermo Fisher Scientific Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: DYNAMICS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 5. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2027
FIGURE 14. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2027
FIGURE 23. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 58. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 59. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SCORES
TABLE 77. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: RANKING
TABLE 80. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 81. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 82. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 83. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 84. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 85. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 86. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3P Biopharmaceuticals
  • Abbott
  • AbbVie Inc.
  • ABN Cleanroom Technology
  • AC Immune
  • Baker Perkins Ltd
  • Bayer AG
  • Bosch Packaging Technology
  • Chemtrix
  • Continuous Pharmaceutical
  • Coperion GmbH
  • Corning Life Sciences
  • Eli Lilly and Company
  • GEA
  • Gebrüder Lödige Maschinenbau GmbH
  • Genzyme Corporation
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Janssen Global Services, LLC
  • Johnson & Johnson’s,
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Novartis AG
  • S K Biotek Ltd
  • Scott Equipment Company
  • Siemens AG
  • Sturtevant, Inc
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...